Potential depot medroxyprogesterone acetate-triggered torsades de pointes in a case of congenital type 2 long QT syndrome
Giudicessi, J.R.; Brost, B.C.; Traynor, K.D.; Ackerman, M.J.
Heart Rhythm 9(7): 1143-1147
2012
ISSN/ISBN: 1556-3871 PMID: 22322327 DOI: 10.1016/j.hrthm.2012.02.006Document Number: 565176
Document emailed within 0-6 h
Related Documents
Zia, Y.; Tang, J.H.; Chinula, L.; Tegha, G.; Stanczyk, F.Z.; Kourtis, A.P. 2019: Medroxyprogesterone acetate concentrations among HIV-infected depot-medroxyprogesterone acetate users receiving antiretroviral therapy in Lilongwe, Malawi Contraception 100(5): 402-405Okada, T.; Miyata, S.; Hashimoto, K.; Maie, K-ichi.; Mochizuki, S. 2007: Takotsubo cardiomyopathy associated with torsades de pointes and long QT interval: a case report Journal of Cardiology 50(1): 83-88
Kaunitz, A.M. 1994: Long-acting injectable contraception with depot medroxyprogesterone acetate American Journal of Obstetrics and Gynecology 170(5 Pt 2): 1543-1549
Cundy, T.; Cornish, J.; Roberts, H.; Reid, I.R. 2002: Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception American Journal of Obstetrics and Gynecology 186(5): 978-983
Modesto, W.; Bahamondes, M.V.; Bahamondes, L. 2015: Prevalence of Low Bone Mass and Osteoporosis in Long-Term Users of the Injectable Contraceptive Depot Medroxyprogesterone Acetate Journal of Women's Health 24(8): 636-640
Cheewadhanaraks, S. 2013: Cumulative recurrence rates of endometriosis-associated pain after long-term intramuscular depot medroxyprogesterone acetate therapy Journal of the Medical Association of Thailand 96(2): 140-143
Wilailak, S.; Vipupinyo, C.; Suraseranivong, V.; Chotivanich, K.; Kietpeerakool, C.; Tanapat, Y.; Therasakvichya, S.; Hamontri, S.; Linasmita, V.; Bunyapipat, S.; Chindavijak, S.; Ittiwisavakul, K.; Khemapech, N.; Suekwattana, P.; Thanapprapasr, D.; Lumbiganon, P. 2012: Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case-control study Bjog: An International Journal of Obstetrics and Gynaecology 119(6): 672-677
Wakatsuki, A.; Okatani, Y.; Fukaya, T. 2003: Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance Circulation 107(20): E197; Author Reply E197
Sturm, G.; Antal, E.; Schmidt Rhode, P.; Bauer, T.; Schulz K D. 1986: Medroxyprogesterone acetate and immunoreactive medroxyprogesterone acetate metabolites measured by two different selective radioimmunoassay antibodies in medroxyprogesterone acetate treated breast cancer patients Anticancer Research 6(3 Part A): 362
Krashin, J.W.; Stuart, G.S.; Garrett, J.; Spector, H.; Bryant, A.G.; Charm, S.; Morse, J.E. 2017: Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion Obstetrics and gynecology 130(1): 109-117
Wong, A.Y.K.; Tang, L.C.H.; Chin, R.K.H. 2010: Levonorgestrel-releasing intrauterine system (Mirena) and Depot medroxyprogesterone acetate (Depoprovera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised controlled trial Australian and New Zealand Journal of Obstetrics and Gynaecology 50(3): 273-279
Boschitsch, E.; Gitsch, E.; Spona, J. 1983: Therapy of the surgical menopause syndrome with depot medroxyprogesterone acetate and its objective evaluation testing the reaction of the anterior pituitary gland to stimulation with gonadotropin-releasing hormone Wiener Klinische Wochenschrift 95(20): 718-724
Bonhomme, M.G.; Potts, D.M.; Fortney, J.A.; Allen, M.Y. 1991: Safety of depot medroxyprogesterone acetate Lancet 338(8772): 942
Bakry, S.; Merhi, Z.O.; Scalise, T.J.; Mahmoud, M.S.; Fadiel, A.; Naftolin, F. 2008: Depot-medroxyprogesterone acetate: an update Archives of Gynecology and Obstetrics 278(1): 1-12
Cromwell, P.; Anyan, W. 1998: Depot medroxyprogesterone acetate galactorrhea Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 23(2): 61
Mishell, D.R. 1996: Pharmacokinetics of depot medroxyprogesterone acetate contraception Journal of Reproductive Medicine 41(5 Suppl): 381-390
Cullins, V.E. 1996: Noncontraceptive benefits and therapeutic uses of depot medroxyprogesterone acetate Journal of Reproductive Medicine 41(5 Suppl): 428-433
Kaunitz, A.M.; Grimes, D.A. 2011: Removing the black box warning for depot medroxyprogesterone acetate Contraception 84(3): 212-213
Frederiksen, M.C. 1996: Depot medroxyprogesterone acetate contraception in women with medical problems Journal of Reproductive Medicine 41(5 Suppl): 414-418
Sathyamala, C.; Shah, P.; Jain, Y.; Bhargava, A. 1994: Use of injectable depot medroxyprogesterone acetate in lactating Indian women Lancet 344(8915): 134-135